Oesophageal Cancer Trial, Recruiting NCT06366828 Sponsor: University Medical Center Groningen Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT06366828
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a tumor in the esophagus (the tube connecting the throat to the stomach) that has been confirmed or is suspected to be esophageal cancer
  • People who had a generally good level of physical functioning at the time of treatment (rated 0–2 on a standard health scale used by doctors)
  • People who are older than 18 years of age
  • People whose cancer had not spread to distant parts of the body at the time of treatment
  • People who received a combination of chemotherapy and radiation therapy before surgery, and who had or were planned to have their esophagus surgically removed, between 2015 and 2021 at one of the hospitals taking part in this trial

Who may not be able to join:

  • People whose esophageal tumor was a specific type called sarcoma, neuro-endocrine carcinoma, or small cell carcinoma
  • People who had their surgical procedure performed at a hospital that is not participating in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0503616161

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2023
Est. completion
1 June 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Multivariable NTCP models will be developed for the prediction of the following; Cardiac events grade II or higher (CTCAE v 5.0), including:; Mortality; Complication Sum Score, that will be determined in Delphi consensus

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov